APA (7th ed.) Citation

S, N., F, V., G, C., R, M., B, R. P., F, B., . . . M, N. (2026). Targeted therapies in non-small cell lung cancer and their cardiovascular impact: Mechanisms, clinical profiles, and strategies of management. Frontiers in pharmacology, 17, 1790897. https://doi.org/10.3389/fphar.2026.1790897

Chicago Style (17th ed.) Citation

S, Nardin, et al. "Targeted Therapies in Non-small Cell Lung Cancer and Their Cardiovascular Impact: Mechanisms, Clinical Profiles, and Strategies of Management." Frontiers in Pharmacology 17 (2026): 1790897. https://doi.org/10.3389/fphar.2026.1790897.

MLA (9th ed.) Citation

S, Nardin, et al. "Targeted Therapies in Non-small Cell Lung Cancer and Their Cardiovascular Impact: Mechanisms, Clinical Profiles, and Strategies of Management." Frontiers in Pharmacology, vol. 17, 2026, p. 1790897, https://doi.org/10.3389/fphar.2026.1790897.